Whereas ApoB100 synthesis is a rate-determining step in hepatocyte lipid export, decreased synthesis of this protein was observed in patients with NASH [60], suggesting that impaired VLDL-TG secretion exacerbates NAFLD. Here, APOB is linked to metabolic dysfunction-associated steatotic liver disease.